Combination of Sarcopenia and Hypoalbuminemia Is a Poor Prognostic Factor in Surgically Treated Nonmetastatic Renal Cell Carcinoma

Purpose: The purpose of this study is to observe how preoperative sarcopenia and hypoalbuminemia affect the oncological outcome of nonmetastatic renal cell carcinoma (RCC) after partial or radical nephrectomy. Methods: This study retrospectively analyzes 288 Japanese patients with nonmetastatic RCC...

Full description

Bibliographic Details
Main Authors: Tomoyuki Makino, Kouji Izumi, Hiroaki Iwamoto, Suguru Kadomoto, Atsushi Mizokami
Format: Article
Language:English
Published: MDPI AG 2023-06-01
Series:Biomedicines
Subjects:
Online Access:https://www.mdpi.com/2227-9059/11/6/1604
_version_ 1797595972010770432
author Tomoyuki Makino
Kouji Izumi
Hiroaki Iwamoto
Suguru Kadomoto
Atsushi Mizokami
author_facet Tomoyuki Makino
Kouji Izumi
Hiroaki Iwamoto
Suguru Kadomoto
Atsushi Mizokami
author_sort Tomoyuki Makino
collection DOAJ
description Purpose: The purpose of this study is to observe how preoperative sarcopenia and hypoalbuminemia affect the oncological outcome of nonmetastatic renal cell carcinoma (RCC) after partial or radical nephrectomy. Methods: This study retrospectively analyzes 288 Japanese patients with nonmetastatic RCC who underwent radical treatment at Kanazawa University Hospital between October 2007 and December 2018. Relationships between sarcopenia as indicated by the psoas muscle mass index and hypoalbuminemia (albumin ≤ 3.5 g/dL) with overall survival (OS) and metastasis-free survival (MFS) were determined. Results: The study found that 110 (38.2%) of the 288 patients were sarcopenic and 29 (10.1%) had hypoalbuminemia. The combination of sarcopenia and hypoalbuminemia was associated with a shorter OS and MFS (<i>p</i> for trend = 0.0007 and <0.0001, respectively), according to Kaplan–Meier curves. The concurrent presence of sarcopenia and hypoalbuminemia were found to be significant and independent predictors of poor MFS (hazard ratio (HR), 2.96; 95% confidence interval (95% CI), 1.05–8.39; <i>p</i> = 0.041) and poor OS (HR, 6.87; 95% CI, 1.75–26.94; <i>p</i> = 0.006), respectively. Conclusions: In Japanese patients with surgically treated nonmetastatic RCC, combined preoperative sarcopenia and hypoalbuminemia was a significant predictor of poor survival.
first_indexed 2024-03-11T02:44:55Z
format Article
id doaj.art-93ce57b00a77465b8ebbcc8376433c9b
institution Directory Open Access Journal
issn 2227-9059
language English
last_indexed 2024-03-11T02:44:55Z
publishDate 2023-06-01
publisher MDPI AG
record_format Article
series Biomedicines
spelling doaj.art-93ce57b00a77465b8ebbcc8376433c9b2023-11-18T09:25:39ZengMDPI AGBiomedicines2227-90592023-06-01116160410.3390/biomedicines11061604Combination of Sarcopenia and Hypoalbuminemia Is a Poor Prognostic Factor in Surgically Treated Nonmetastatic Renal Cell CarcinomaTomoyuki Makino0Kouji Izumi1Hiroaki Iwamoto2Suguru Kadomoto3Atsushi Mizokami4Department of Integrative Cancer Therapy and Urology, Kanazawa University Graduate School of Medical Science, 13-1 Takara-Machi, Kanazawa 920-8640, JapanDepartment of Integrative Cancer Therapy and Urology, Kanazawa University Graduate School of Medical Science, 13-1 Takara-Machi, Kanazawa 920-8640, JapanDepartment of Integrative Cancer Therapy and Urology, Kanazawa University Graduate School of Medical Science, 13-1 Takara-Machi, Kanazawa 920-8640, JapanDepartment of Integrative Cancer Therapy and Urology, Kanazawa University Graduate School of Medical Science, 13-1 Takara-Machi, Kanazawa 920-8640, JapanDepartment of Integrative Cancer Therapy and Urology, Kanazawa University Graduate School of Medical Science, 13-1 Takara-Machi, Kanazawa 920-8640, JapanPurpose: The purpose of this study is to observe how preoperative sarcopenia and hypoalbuminemia affect the oncological outcome of nonmetastatic renal cell carcinoma (RCC) after partial or radical nephrectomy. Methods: This study retrospectively analyzes 288 Japanese patients with nonmetastatic RCC who underwent radical treatment at Kanazawa University Hospital between October 2007 and December 2018. Relationships between sarcopenia as indicated by the psoas muscle mass index and hypoalbuminemia (albumin ≤ 3.5 g/dL) with overall survival (OS) and metastasis-free survival (MFS) were determined. Results: The study found that 110 (38.2%) of the 288 patients were sarcopenic and 29 (10.1%) had hypoalbuminemia. The combination of sarcopenia and hypoalbuminemia was associated with a shorter OS and MFS (<i>p</i> for trend = 0.0007 and <0.0001, respectively), according to Kaplan–Meier curves. The concurrent presence of sarcopenia and hypoalbuminemia were found to be significant and independent predictors of poor MFS (hazard ratio (HR), 2.96; 95% confidence interval (95% CI), 1.05–8.39; <i>p</i> = 0.041) and poor OS (HR, 6.87; 95% CI, 1.75–26.94; <i>p</i> = 0.006), respectively. Conclusions: In Japanese patients with surgically treated nonmetastatic RCC, combined preoperative sarcopenia and hypoalbuminemia was a significant predictor of poor survival.https://www.mdpi.com/2227-9059/11/6/1604renal cell carcinomasarcopeniaalbuminpsoas muscle mass indexsurvivalmetastasis
spellingShingle Tomoyuki Makino
Kouji Izumi
Hiroaki Iwamoto
Suguru Kadomoto
Atsushi Mizokami
Combination of Sarcopenia and Hypoalbuminemia Is a Poor Prognostic Factor in Surgically Treated Nonmetastatic Renal Cell Carcinoma
Biomedicines
renal cell carcinoma
sarcopenia
albumin
psoas muscle mass index
survival
metastasis
title Combination of Sarcopenia and Hypoalbuminemia Is a Poor Prognostic Factor in Surgically Treated Nonmetastatic Renal Cell Carcinoma
title_full Combination of Sarcopenia and Hypoalbuminemia Is a Poor Prognostic Factor in Surgically Treated Nonmetastatic Renal Cell Carcinoma
title_fullStr Combination of Sarcopenia and Hypoalbuminemia Is a Poor Prognostic Factor in Surgically Treated Nonmetastatic Renal Cell Carcinoma
title_full_unstemmed Combination of Sarcopenia and Hypoalbuminemia Is a Poor Prognostic Factor in Surgically Treated Nonmetastatic Renal Cell Carcinoma
title_short Combination of Sarcopenia and Hypoalbuminemia Is a Poor Prognostic Factor in Surgically Treated Nonmetastatic Renal Cell Carcinoma
title_sort combination of sarcopenia and hypoalbuminemia is a poor prognostic factor in surgically treated nonmetastatic renal cell carcinoma
topic renal cell carcinoma
sarcopenia
albumin
psoas muscle mass index
survival
metastasis
url https://www.mdpi.com/2227-9059/11/6/1604
work_keys_str_mv AT tomoyukimakino combinationofsarcopeniaandhypoalbuminemiaisapoorprognosticfactorinsurgicallytreatednonmetastaticrenalcellcarcinoma
AT koujiizumi combinationofsarcopeniaandhypoalbuminemiaisapoorprognosticfactorinsurgicallytreatednonmetastaticrenalcellcarcinoma
AT hiroakiiwamoto combinationofsarcopeniaandhypoalbuminemiaisapoorprognosticfactorinsurgicallytreatednonmetastaticrenalcellcarcinoma
AT sugurukadomoto combinationofsarcopeniaandhypoalbuminemiaisapoorprognosticfactorinsurgicallytreatednonmetastaticrenalcellcarcinoma
AT atsushimizokami combinationofsarcopeniaandhypoalbuminemiaisapoorprognosticfactorinsurgicallytreatednonmetastaticrenalcellcarcinoma